title: Diagnosis of venous leakage by 133Xe corporeal clearance after intracavernous injection of prostaglandin E1 in poorly responding patients.
abstract: 133Xe corporeal clearance after intracavernous (IC) prostaglandin E1 (PGE-1) injection was assessed in detecting venous leakage (VL) in a group of impotent patients with poor clinical response to PGE-1 injection. 133Xe corporeal washouts were done in the flaccid state and at full erection or at 20 min after the IC injection of 20 micrograms PGE-1 in cases where no full erection occurred in sequence on two separate days. In each case, data were acquired in frame mode after intracorporeal injection on one side of the midline just behind the glans of 0.1 ml, namely, 1-2 mCi (34-74 MBq) 133Xe in saline for 20 min. A time-activity curve was generated from the region of interest (ROI) at the site of injection and a computer routine was used to calculate clearance half-time (T1/2) in min and flow rate (Q) in ml per 100 g tissue per min. The data of 20 patients with equivocal response to IC PGE-1 were analysed. Of them, 14 had venous leakage and six had no vascular impairment (NVI). Venous leakage was proved by Doppler analysis, cavernosography after PGE-1, and/or selective arteriography. Twelve of 14 patients with VL had enhanced 133Xe corporeal clearance after PGE-1 with a significant decrease in T1/2 (mean +/- S.D.) from 115.9 +/- 196.0 to 13.3 +/- 13.4 (P less than 0.05) and increase in Q from 2.1 +/- 2.2 to 7.5 +/- 5.6 (P less than 0.01). In contrast, all six patients with NVI had decreased 133Xe corporeal clearance.(ABSTRACT TRUNCATED AT 250 WORDS)
authors.affiliation: Department of Nuclear Medicine, Veterans General Hospital, Taipei, Taiwan.
authors.forename: S H
authors.initials: SH
authors.lastname: Yeh
authors.forename: R S
authors.initials: RS
authors.lastname: Liu
authors.forename: K K
authors.initials: KK
authors.lastname: Chen
authors.forename: L C
authors.initials: LC
authors.lastname: Wu
authors.forename: M N
authors.initials: MN
authors.lastname: Ng
authors.forename: Y K
authors.initials: YK
authors.lastname: Chu
authors.forename: M T
authors.initials: MT
authors.lastname: Chen
authors.forename: S S
authors.initials: SS
authors.lastname: Chang
mesh_terms: D000368:Aged; D000527:Alprostadil / Q000008:administration & dosage; D007172:Erectile Dysfunction / Q000000981:diagnostic imaging / Q000209:etiology*; D006801:Humans; D008297:Male; D008875:Middle Aged; D010413:Penis / Q000098:blood supply*; D011877:Radionuclide Imaging; D014680:Veins; D014980:Xenon Radioisotopes
chemical_list: D014980:Xenon Radioisotopes; D000527:Alprostadil